spacer
home > pmps > autumn 2017 > making the switch
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making the Switch

The global pharmaceutical manufacturing sector revenue is estimated to increase to around $1,226 billion by 2018. To remain competitive in such a large market, these organisations must optimise processes to create low-expense products without compromising quality. The adoption of continuous manufacturing will offer the industry many benefits.

Pharma production is a well-established sector that provides high-quality and affordable medication to the population. However, manufacturers often rely on older processes rather than adapting to meet the growing needs of consumers.

Traditionally, batch manufacturing produces the majority of drugs sold worldwide – a method that isolates each process. Workers will handle the product at each stage, sending it to be tested in laboratories before the next step. While this works effectively, receiving the final item may take months. Companies are looking for new solutions to reduce costs, environmental impact and development time.

In the boom of Industry 4.0, many sectors, such as chemicals and gas, have implemented more advanced technology to optimise production. Integrated automation systems can streamline an assembly line to efficiently create medication and devices frequently, with little human interaction. Continuous manufacturing is an advancement that developers should utilise to reap the same benefits as these industries.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Jonathan Wilkins is Marketing Director at EU Automation and is also one of the most prolific Industry 4.0 writers in the industrial automation sector. A professional brand advocate and commercial marketing strategist, he has been part of the company since its humble beginnings in 2009 and has over a decade of experience in marketing.
spacer
Jonathan Wilkins
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BBI Solutions broadens antibody portfolio and strengthens reagent technical support capabilities with acquisition of Maine Biotechnology Services

BBI, a leading manufacturer of raw materials and finished test platforms, already provides human antigens, antibodies, serum and plasma products and clinical chemistry enzymes, for the in-vitro diagnostics market. Now with the acquisition of MBS they have strengthened their antibody offering, providing a comprehensive portfolio and custom services to deliver a total reagent solution for any immunoassay development.
More info >>

White Papers

e-tools enhance clinical trial performance

e-novex

In today’s ever-evolving medical business, technological changes require innovation to meet growing market demands and to bring about advances in the industry. One such development currently taking place in the field of clinical research is how e-tools are initiating a boost in the productivity of clinical trials.
More info >>

 
Industry Events

BioTrinity 2018

23-25 April 2018, Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTO’s and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement